David Adler1, Melissa Wallace2, Thola Bennie3, Beau Abar4, Rokhsanna Sadeghi5, Tracy Meiring6, Anna-Lise Williamson7, Linda-Gail Bekker8. 1. 601 Elmwood Avenue, Box 655, Department of Emergency Medicine, University of Rochester, Rochester, NY, 14534 USA. Electronic address: david_adler@urmc.rochester.edu. 2. Desmond Tutu HIV Centre, Institute of Infectious Diseases & Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa. Electronic address: Melissa.Wallace@hiv-research.org.za. 3. Desmond Tutu HIV Centre, Institute of Infectious Diseases & Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa. Electronic address: Thola.Bennie@hiv-research.org.za. 4. 601 Elmwood Avenue, Box 655, Department of Emergency Medicine, University of Rochester, Rochester, NY, 14534 USA. Electronic address: beau_abar@urmc.rochester.edu. 5. 601 Elmwood Avenue, Box 655, Department of Emergency Medicine, University of Rochester, Rochester, NY, 14534 USA. Electronic address: rokhsanna_sadeghi@urmc.rochester.edu. 6. Institute of Infectious Diseases & Molecular Medicine and Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa. Electronic address: tracy.meiring@gmail.com. 7. Institute of Infectious Diseases & Molecular Medicine and Division of Medical Virology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa. Electronic address: anna-lise.williamson@uct.ac.za. 8. Desmond Tutu HIV Centre, Institute of Infectious Diseases & Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, South Africa. Electronic address: linda-gail.bekker@hiv-research.org.za.
Abstract
OBJECTIVES: Persistence of infection with high-risk Human papillomaviruses (HR-HPV) increases the risk of incident and progressive precancerous lesions of the cervix. Rates of HR-HPV persistence have been shown to be increased among HIV-infected adult women, however there is a paucity of literature addressing HPV persistence in the young HIV-infected population. We compared rates of HR-HPV persistence between HIV-infected and HIV-uninfected young women. METHODS: We obtained self-collected vaginal swabs at six-month intervals from 50 HIV-uninfected and 33 HIV-infected young women recruited through a community youth center (age 17-21 years) and compared rates of HR-HPV persistence. HR-HPV testing was conducted using the Roche's Linear Array® HPV Test. RESULTS: Eighty-three prevalent (upon baseline testing) and incident (upon subsequent testing) individual HR-HPV infections were identified among 43 members of the cohort (23 HIV-uninfected and 20 HIV-infected). At twelve months, 19% of baseline HR-HPV infections continued to be present with a statistically significant difference between HIV-uninfected and HIV-infected participants (4% versus 31%; p=0.01). CONCLUSIONS: HIV-infected young women in our cohort had a seven-fold increased rate of persistence of HR-HPV overall at 12 months, indicating an increased risk for incident and progressive precancerous lesions. Identification of persistent infection with HR-HPV may complement cytological findings in determining the need for colposcopy.
OBJECTIVES: Persistence of infection with high-risk Human papillomaviruses (HR-HPV) increases the risk of incident and progressive precancerous lesions of the cervix. Rates of HR-HPV persistence have been shown to be increased among HIV-infected adult women, however there is a paucity of literature addressing HPV persistence in the young HIV-infected population. We compared rates of HR-HPV persistence between HIV-infected and HIV-uninfected young women. METHODS: We obtained self-collected vaginal swabs at six-month intervals from 50 HIV-uninfected and 33 HIV-infected young women recruited through a community youth center (age 17-21 years) and compared rates of HR-HPV persistence. HR-HPV testing was conducted using the Roche's Linear Array® HPV Test. RESULTS: Eighty-three prevalent (upon baseline testing) and incident (upon subsequent testing) individual HR-HPV infections were identified among 43 members of the cohort (23 HIV-uninfected and 20 HIV-infected). At twelve months, 19% of baseline HR-HPV infections continued to be present with a statistically significant difference between HIV-uninfected and HIV-infectedparticipants (4% versus 31%; p=0.01). CONCLUSIONS:HIV-infected young women in our cohort had a seven-fold increased rate of persistence of HR-HPV overall at 12 months, indicating an increased risk for incident and progressive precancerous lesions. Identification of persistent infection with HR-HPV may complement cytological findings in determining the need for colposcopy.
Authors: Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers Journal: Am J Clin Pathol Date: 2012-04 Impact factor: 2.493
Authors: N F Schlecht; S Kulaga; J Robitaille; S Ferreira; M Santos; R A Miyamura; E Duarte-Franco; T E Rohan; A Ferenczy; L L Villa; E L Franco Journal: JAMA Date: 2001-12-26 Impact factor: 56.272
Authors: K L Wallin; F Wiklund; T Angström; F Bergman; U Stendahl; G Wadell; G Hallmans; J Dillner Journal: N Engl J Med Date: 1999-11-25 Impact factor: 91.245
Authors: M A Nobbenhuis; J M Walboomers; T J Helmerhorst; L Rozendaal; A J Remmink; E K Risse; H C van der Linden; F J Voorhorst; P Kenemans; C J Meijer Journal: Lancet Date: 1999-07-03 Impact factor: 79.321
Authors: G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney Journal: J Natl Cancer Inst Date: 1995-09-20 Impact factor: 13.506
Authors: Zizipho Z A Mbulawa; Cari van Schalkwyk; Nai-Chung Hu; Tracy L Meiring; Shaun Barnabas; Smritee Dabee; Heather Jaspan; Jean-Mari Kriek; Shameem Z Jaumdally; Etienne Muller; Linda-Gail Bekker; David A Lewis; Janan Dietrich; Glenda Gray; Jo-Ann S Passmore; Anna-Lise Williamson Journal: PLoS One Date: 2018-01-02 Impact factor: 3.240
Authors: Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily Journal: J Int AIDS Soc Date: 2018-06 Impact factor: 5.396
Authors: Ferralita S Madere; Michael Sohn; Angelina K Winbush; Breóna Barr; Alex Grier; Cal Palumbo; James Java; Tracy Meiring; Anna-Lise Williamson; Linda-Gail Bekker; David H Adler; Cynthia L Monaco Journal: Viruses Date: 2022-02-19 Impact factor: 5.818
Authors: Racheal S Dube Mandishora; Kristina S Gjøtterud; Sonja Lagström; Babill Stray-Pedersen; Kerina Duri; Nyasha Chin'ombe; Mari Nygård; Irene Kraus Christiansen; Ole Herman Ambur; Mike Z Chirenje; Trine B Rounge Journal: Papillomavirus Res Date: 2018-04-30